Provided by Tiger Trade Technology Pte. Ltd.

ADMA Biologics

9.33
-0.0600-0.64%
Post-market: 9.380.0500+0.54%19:35 EDT
Volume:1.76M
Turnover:16.40M
Market Cap:2.09B
PE:13.32
High:9.51
Open:9.38
Low:9.29
Close:9.39
52wk High:20.46
52wk Low:7.21
Shares:223.98M
Float Shares:210.51M
Volume Ratio:1.11
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7004
EPS(LYR):0.6000
ROE:41.90%
ROA:21.78%
PB:5.12
PE(LYR):15.55

Loading ...

Adma Biologics downgraded to Neutral from Overweight at Cantor Fitzgerald

TIPRANKS
·
Mar 26

BUZZ-U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings

Reuters
·
Mar 26

Adma Biologics falls -12.6%

TIPRANKS
·
Mar 26

ADMA Biologics Shares Reverse Premarket Course; Last Down 3%

THOMSON REUTERS
·
Mar 25

BUZZ-U.S. STOCKS ON THE MOVE-Arm, Destiny Tech100, Terns Pharma

Reuters
·
Mar 25

BUZZ-ADMA Biologics rises after rejecting short-seller report

Reuters
·
Mar 25

Adma Biologics addresses misleading report by Culper Research

TIPRANKS
·
Mar 25

ADMA Biologics : Short Report Appears Premised on Speculative Assertions Derived From Unidentified and Unreliable Sources

THOMSON REUTERS
·
Mar 25

ADMA Biologics Inc: Taking Appropriate Steps to Review Assertions in the Short Report

THOMSON REUTERS
·
Mar 25

Culper Research short Adma Biologics, says reported growth ‘a fiction’

TIPRANKS
·
Mar 25

BRIEF-Culper Research Says We Are Short ADMA Biologics

Reuters
·
Mar 25

Assessing ADMA Biologics (ADMA) Valuation After Fresh Analyst Upgrades And Strong Buy Sentiment

Simply Wall St.
·
Mar 23

ADMA Biologics President and CEO Adam S. Grossman disposes of USD 318,360 in common shares

Reuters
·
Mar 18

FDA-Approved Yield Boost For ASCENIV Might Change The Case For Investing In ADMA Biologics (ADMA)

Simply Wall St.
·
Mar 17

Insider Confidence Surges as ADMA Biologics Director Makes Bold Move

TIPRANKS
·
Mar 10

Is ADMA Biologics (ADMA) Attractive After Recent Share Price Swings And DCF Upside?

Simply Wall St.
·
Mar 05

Stock Track | ADMA Biologics Soars 5.20% Intraday on $125 Million Share Repurchase Announcement with JPMorgan

Stock Track
·
Mar 02

ADMA Biologics launches $125 million accelerated share repurchase with JPMorgan

Reuters
·
Mar 02

ADMA Biologics Files Initial Beneficial Ownership Statement for CFO and Treasurer Terry Kohler

Reuters
·
Feb 27

BRIEF-ADMA Biologics Says Brad Tade Is Retiring As Chief Financial Officer

Reuters
·
Feb 26